Nice talk by W Tong at #ISMBECCB21 (CAMDA session) discussing the FDA perspective on how to do AI for regulatory science. He presents the TRIAL framework: transparency, reliability, interpretability, applicability & liability. #ISMBECCB2021
In relation to interpretability, he discusses InferBert
(https://www.frontiersin.org/articles/10.3389/frai.2021.659622/full) which builds a Bayesian causality framework (using the Do-calculus) for interpreting the BERT transformer based model. #ISMBECCB21 #ISMBECCB2021
linkstream2 microblog 